Abstract: The disclosure relates to a lighting apparatus of a helicopter deck, which is meant especially while being installed in connection with an identification marking, such as an H, triangle, cross figure or the like, and/or a touchdown and positioning mark ring on a landing and takeoff area of the helicopter deck for illuminating the safety marking/markings in question in order to make more efficient observing thereof from the air. The lighting apparatus includes of light units formed of one or more lamps and being operable by power supply transmitted from a power source in connection with the helicopter deck, wherein the light units are coupled essentially immovably in connection with an upper surface of the helicopter deck.

Abstract: The disclosure relates to a lighting apparatus of a helicopter deck, which is meant especially while being installed in connection with an identification marking, such as an H, triangle, cross figure or the like, and/or a touchdown and positioning mark ring on a landing and takeoff area of the helicopter deck for illuminating the safety marking/markings in question in order to make more efficient observing thereof from the air. The lighting apparatus includes of light units formed of one or more lamps and being operable by power supply transmitted from a power source in connection with the helicopter deck, wherein the light units are coupled essentially immovably in connection with an upper surface of the helicopter deck.

Abstract: The invention relates to a new composition for use on a pharmaceutical granule. The composition is three-layered, comprising as the innermost layer a substantially pure fat, as the middle layer a mixture of fat and polymer, and as the outermost layer again a substantially pure fat.The composition according to the invention produces a preparation which is tasteless, especially when administered in the form of a powder or a mixture, even if the phrmaceutical to be dosed has a bad taste. Also, the preparation keeps well in mixture, and it enables a pharmaceutical to be transported past the stomach for release/absorption at the beginning of the small intestine.

Abstract: The invention relates to a new antibiotic compound, acetyl erythromycin stearate having formula I ##STR1## The compound according to the invention is absorbed readily from the alimentary tract. Gastric acid does not convert the compound according to the invention to an uneffective form as is the case with some other erythromycin antibiotics. Absorbing is good also when the patient eats when taking the new medicine.The compound according to the invention is prepared by reacting erythromycin base with acetyl halide in an organic solvent in the presence of an acid acceptor. The stearate salt is prepared from the obtained ester without in between isolating the ester.